Justin Trojanowski - 30 Sep 2022 Form 3 Insider Report for Tempest Therapeutics, Inc. (TPST)

Role
Corporate Controller
Signature
/s/ Jason Minio, Attorney-in-Fact
Issuer symbol
TPST
Transactions as of
30 Sep 2022
Net transactions value
$0
Form type
3
Filing time
04 Oct 2022, 08:00:31 UTC
Next filing
04 Oct 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding TPST Employee Stock Option (right to buy) 30 Sep 2022 Common Stock 5,000 $2.29 Direct F1
holding TPST Employee Stock Option (right to buy) 30 Sep 2022 Common Stock 10,000 $2.29 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-fourth (1/4) of the shares underlying the option will vest on June 27, 2023 and the remainder will vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service through each vesting date.
F2 One-fourth (1/4) of the shares underlying the option will vest on July 1, 2023 and the remainder will vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service through each vesting date.

Remarks:

Exhibit List - Exhibit 24 -Power of Attorney